QTMeds

Drug Database Monograph

ILUMETRI 100 mg

PENDING REVIEW

Active Ingredient: TILDRAKIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69596271

← Back to Prescription Analyzer